Verastem Oncology (NASDAQ: VSTM) received Fast Track Designation from the U.S. Food and Drug Administration for VS-7375, an oral investigational ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE